Literature DB >> 11193892

New analogues of camptothecins. Activity and resistance.

E Boven1, A H Van Hattum, I Hoogsteen, H M Schlüper, H M Pinedo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11193892     DOI： 10.1111/j.1749-6632.2000.tb07035.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Design, semisynthesis and potent cytotoxic activity of novel 10-fluorocamptothecin derivatives.

Authors:  Cheng-Jie Yang; Zi-Long Song; Masuo Goto; Pei-Ling Hsu; Xiao-Shuai Zhang; Qian-Ru Yang; Ying-Qian Liu; Mei-Juan Wang; Susan L Morris-Natschke; Xiao-Fei Shang; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2017-09-08       Impact factor: 2.823

2.  Design, synthesis and potent cytotoxic activity of novel 7-(N-[(substituted-sulfonyl)piperazinyl]-methyl)-camptothecin derivatives.

Authors:  Gao-Xiang Zhu; Pi-Le Cheng; Masuo Goto; Na Zhang; Susan L Morris-Natschke; Kan-Yen Hsieh; Guan-Zhou Yang; Qian-Ru Yang; Ying-Qian Liu; Hai-Le Chen; Xiao-Shuai Zhang; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2017-02-28       Impact factor: 2.823

3.  Design and synthesis of new 7-(N-substituted-methyl)-camptothecin derivatives as potent cytotoxic agents.

Authors:  Xiao-Bo Zhao; Masuo Goto; Zi-Long Song; Susan L Morris-Natschke; Yu Zhao; Dan Wu; Liu Yang; Shu-Gang Li; Ying-Qian Liu; Gao-Xiang Zhu; Xiao-Bing Wu; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem Lett       Date:  2014-06-27       Impact factor: 2.823

Review 4.  DNA topoisomerase-targeting chemotherapeutics: what's new?

Authors:  Selma M Cuya; Mary-Ann Bjornsti; Robert C A M van Waardenburg
Journal:  Cancer Chemother Pharmacol       Date:  2017-05-20       Impact factor: 3.288
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.